BURGDORF, Switzerland and INDIANAPOLIS, Nov. 19, 2020 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) and Ypsomed (SWX: YPSN) announced today a non-exclusive, global agreement to advance an ...

Abbott is announcing plans for a three-way collaboration to put forward an automated insulin delivery system in Europe by the end of this year, connected to its FreeStyle Libre 3 wearable glucose ...

Abbott Laboratories has taken a big step in diabetes management by integrating its glucose sensor with a Tandem insulin pump, creating a hybrid closed-loop insulin delivery system. The two companies ...

(RTTNews) - Eli Lilly and Co. (LLY) and Swiss medical device maker Ypsomed AG announced Thursday a non-exclusive, global agreement to advance an automated insulin delivery system as part of Lilly's ...

Abbott, CamDiab and Ypsomed today announced that they are partnering to develop and commercialize an integrated automated insulin delivery (AID) system to help lessen the burden of round-the-clock ...

Dublin, Oct. 28, 2025 (GLOBE NEWSWIRE) -- The "United States Insulin Pump Market Outlook 2025-2033" report has been added to ResearchAndMarkets.com's offering. The United States Insulin Pump Market is ...

ZURICH, March 7 (Reuters) - Swiss insulin pump maker Ypsomed, responding to a report on Wednesday that had sent its shares tumbling, said 2019/20 profit will likely fall amid market uncertainties but ...

Every time Vanessa publishes a story, you’ll get an alert straight to your inbox! Enter your email By clicking “Sign up”, you agree to receive emails from ...

(MENAFN- GlobeNewsWire - Nasdaq) The United States Insulin Pump Market is projected to grow from US$ 1.55 billion in 2024 to US$ 2.58 billion in 2033, with a CAGR of 5.84% from 2025-2033. This growth ...